Laboratory Procedure BD Affirm VPIII Ambient Temperature Transport System

Similar documents
STEP-BY-STEP INSTRUCTIONS FOR INVESTIGATIONAL USE. Rapid HCV Antibody Test FOR ORAQUICK RAPID HCV ANTIBODY TEST

Recommendations for the Safe Use of Handling of Cytotoxic Drugs

Leader s Guide E4017. Bloodborne Pathogens: Always Protect Yourself

Biosafety Spill Response Guide

BD Affirm VPIII. Microbial Identification System

Laboratory Biosafty In Molecular Biology and its levels

Bloodborne Pathogens Program Revised July,

Policies. Prep Room Policies

MEDICAL WASTE MANAGEMENT

Biohazardous Waste and Sharps Disposal

Revision 5. Calvin College Medical Waste Management Plan. Date: Health and Safety

Use and Disposal of Sharps

Title: Panbio Dengue IgG Indirect ELISA Revision Date : Sep. 03, 2013

Roger Williams University. Bloodborne Pathogens Exposure Control Plan

APPENDIX A GUIDANCE DOCUMENT

Bloodborne Pathogens (BBPs) Louisiana Delta Community College

The University of Texas at San Antonio Office of Environmental Health, Safety and Risk Management. Part A. Biological Waste Management Safety Plan

Annual Biomedical Waste Code Training

Health Care Workers in the Community

How Does a Doctor Test for AIDS?

STANDARD OPERATING PROCEDURES Safe Autoclave Operations

ClikSTAR - Important facts about your new insulin delivery device.

AUTOCLAVE PROGRAM. SOP Bio-006 FOR THE USE OF AUTOCLAVE FOR STERILIZATION OF MATERIALS AND BIOLOGICAL WASTE SOP

Biohazardous Waste Management Plan

INFECTION CONTROL POLICY MANUAL

Guidance Document Infectious Substances

VACUETTE RNAgard Blood Tubes BioMaxi Blood RNA Purification Kit. For the collection, preservation and purification of RNA from whole blood

Infectious Waste Management Plan

PI s Name Date Bldg./Rm# CDC Biosafety Level 3 (BSL-3)

Biological Safety Program

& OSHA STANDARDS TARGET GROUP: Core Campus Nursing Students SECTION: Academic

THE UNIVERSITY OF MAINE BIOMEDICAL WASTE MANAGEMENT PLAN

Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011

POLICY 08:18:00 BLOODBORNE PATHOGENS CONTROL PLAN

Brock University Facilities Management Operating Procedures

Gravity Bag Cord Blood Collection Method Training Manual

MATERIAL SAFETY DATA SHEET

Blood Borne Pathogen Exposure Control Plan Checklist

6.0 Infectious Diseases Policy: Student Exposure Control Plan

TARLETON STATE UNIVERSITY Biohazardous Waste Program

Biohazardous, Medical & Biological Waste Guidance Chart

INFECTION CONTROL PRECAUTIONS

SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS

UNIVERSITY OF RICHMOND REGULATED MEDICAL WASTE MANAGEMENT GUIDELINES

Safe Operating Procedure

SECTION 1 - PRODUCT IDENTIFICATION

THE UNIVERSITY OF NEWCASTLE- SCHOOL of BIOMEDICAL SCIENCES

Response to Biological Spills in the Laboratory (Intentional or Accidental)

INSTITUTIONAL POLICY AND PROCEDURE (IPP)

Bloodborne Pathogens

Policy for the Disposal of Biological Waste

SAFETY DATA SHEET EVO-STIK GRIPFILL SOLVENT FREE (Irl)

Decontamination and Waste Management

KGI MEDICAL WASTE MANAGEMENT PLAN

STANDARD OPERATING PROCEDURE

Scott & White Institutional Biosafety Committee Compliance Program Biohazardous Material Spill Clean-Up Procedure Policy #IBC.002

JAC-CEN-DEL COMMUNITY SCHOOLS BLOODBORNE PATHOGENS UNIVERSAL PRECAUTIONS A BACK TO SCHOOL TRADITION

Bloodborne Pathogens. Updated

SAFETY DATA SHEET. according to 1907/2006/EC, Article 31 CYTOFIXX (CYTOLOGICAL FIXATIVE)

CITY OF CHESTERFIELD POLICE DEPARTMENT GENERAL ORDER EFFECTIVE: MAY 5, 2011 CANCELS: GENERAL ORDER

Edith Cowan University Faculty of Health, Engineering and Science Work Health and Safety Committee

OESO Ergonomics Division ERGO(3746) Duke Police Corporate Risk Management

Biohazardous Waste Disposal. Table of Contents

The following standard practices, safety equipment, and facility requirements apply to BSL-1:

KwikPen Insulin delivery device

Administrative Procedure

Utah Division of Solid and Hazardous Waste Solid Waste Management Program

MEDICAL WASTE DISPOSAL POLICY. EFFECTIVE DATE: January 31, 1991 REVISED DATE: April 1, 2008 I. AUTHORITY TO ESTABLISH DISPOSAL POLICY:

02.11 Food and Nutrition Services

SAFETY DATA SHEET BOSTIK AQUAGRIP 536

Blood-borne viruses in the workplace Guidance for employers and employees

Shop Safety. Action Tattoo 3525 Del Mar Heights Rd., Suite 7 San Diego, CA 92130

FLORENCE TOWNSHIP BOARD OF EDUCATION FILE CODE: / Florence, New Jersey

How to safely collect blood samples from persons suspected to be infected with highly infectious blood-borne pathogens (e.g.

SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT

4. Infection control measures

Corporate Safety Infection Prevention Employee Health

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

: Microscope Slide containing Various Human or Animal Blood samples

Biosafety Level 2 Criteria

Creation Date: Revision Date: Page: 1 of 7

Appendix J IBC Biohazard Spill Management Plan

BODY SUBSTANCE ISOLATION (BSI): THE STANDARD OF CARE

Biohazard - Anything that is harmful or potentially harmful to man, other species or the environment.

OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA)

HUMULIN 70/30 KwikPen

Aseptic Technique. A GMP/GTP Training Module

OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:

INFECTION CONTROL POLICY

A Guide to Managing Your Biological Waste at the University at Albany

Biomedical Waste Management Plan

Private Water Supplies Sampling Manual. A Field Guide

Biomedical. Waste Management Guide

COMPOSITION / INFORMATION ON INGREDIENTS

Grady Hospital Waste Management Program For Grady Health System. An Update

Carnegie Mellon University s Policy and Procedures for Recombinant and Synthetic Nucleic Acid Materials Spills

Precautions for Handling and Disposal of Dead Bodies

BSL 1 Laboratory Biosafety Manual

Transcription:

Laboratory Procedure BD Affirm VPIII Ambient Temperature Transport System For collection and extended transport of vaginal specimens for use in the Affirm VPIII Microbial Identification Test. I. INTENDED USE Affirm VPIII Ambient Temperature Transport is a sterile ready-to-use system intended for the collection, transport and preservation of vaginal specimens for use only with the Affirm VPIII Microbial Identification Test. The Affirm VPIII Ambient Temperature Transport System (ATTS) should be used with those specimens where transport times are expected to exceed 1 h at ambient temperature (15 30ºC) or 4 h at refrigerated temperatures (2 8ºC). II. SUMMARY One of the routine procedures in the use of the Affirm VPIII Microbial Identification Test involves the collection and stable transportation of a vaginal specimen from the patient to the laboratory. This can be accomplished using the Affirm VPIII Ambient Temperature Transport System. The Affirm VPIII Ambient Temperature Transport System is designed to stabilize the nucleic acid of Candida species, Gardnerella vaginalis, and Trichomonas vaginalis during specimen transport at ambient temperature (15 30ºC) for up to 72 h. This system has also been qualified for transport use at 2 8ºC. The Ambient Temperature Transport Reagent Dropper contents are dispensed into the Sample Collection Tube. The patient vaginal specimen is immediately collected and the polyester-tip swab containing the patient specimen is placed in the Sample Collection Tube containing the Ambient Temperature Transport Reagent. The swab shaft is broken at the scored point and the top portion of the swab is discarded. The Sample Collection Cap is placed over the exposed end of the swab and is firmly seated on the Sample Collection Tube. The capped Sample Collection Tube is sealed in the outer bag of the Affirm VPIII Ambient Temperature Transport System and transported to the laboratory within 72 h. III. PRINCIPLES OF THE PROCEDURE When a vaginal specimen is collected and processing is delayed past the recommended time frame, changes in the specimen may result in erroneous Affirm VPIII test results. The formulation of the ATTS Reagent and the design of the transport system allows preservation of the nucleic acids and inhibits growth of Candida sp., Gardnerella vaginalis and Trichomonas vaginalis from patient specimens for up to 72 h under ambient as well as refrigerated conditions.

IV. REAGENTS Warnings and Precautions: For in vitro Diagnostic Use Affirm VPIII Transport Reagent: Substance is toxic and highly flammable. Irritating to eyes, respiratory system and skin. Use in a well-ventilated place. Keep away from sources of ignition. No smoking. Wear protective clothing and gloves. Immediately remove any clothing soiled by the product. If inhaled, supply fresh air or oxygen; consult Material Safety Data Sheet (MSDS) and seek medical advice. After skin contact, immediately rinse with water. After eye contact, rinse immediately with plenty of water, consult MSDS and seek medical advice. Proper handling and disposal methods should be established. Wipe up any spillage of patient specimens immediately and disinfect with an appropriate disinfectant. Treat the cleaning materials as biohazardous waste. The polyester-tip swab should not be used if the packaging is opened or damaged. The Ambient Temperature Transport System should not be used if its foil pouch is open or the ATTS Reagent Dropper is damaged. When specimen transport times exceed 72 h, a reduction in sensitivity may be observed. Preparation and Storage of materials: All materials are supplied ready for use. Store at ambient temperature (15 30ºC). Keep away from heat contents are flammable (see Precautions ). V. MATERIALS PROVIDED 1. Instructions for Sample Collection, 1 package insert. 2. Affirm VPIII Ambient Temperature Transport System, 10 (446253) and 100 (446255). Each plastic pouch in the Affirm VPIII Ambient Temperature Transport System contains what is required to collect one vaginal specimen for use only with the Affirm VPIII Microbial Identification Test. Each Affirm VPIII Ambient Temperature Transport System includes: - Individually wrapped, pre-scored, sterile polyester-tip swab - Sample Collection Tube - Sample Collection Cap - Ambient Temperature Transport Reagent Dropper (in foil pouch). 3. Patient Specimen Labels, 24 labels (446253) and 240 labels (446255) 2

VI. SPECIMEN COLLECTION The Affirm VPIII Ambient Temperature Transport System was designed for use with those specimens where transport times are expected to exceed 1 h at ambient temperature or 4 h at refrigerated temperatures. WARNING: Pathogenic microorganisms, including Hepatitis Viruses and Human Immunodeficiency Virus, may be present in clinical specimens. Standard Precautions 1 4 and institutional guidelines should be followed in handling all items contaminated with blood and other body fluids. VII. PROCEDURE NOTE: READ ALL INSTRUCTIONS CAREFULLY BEFORE PROCEEDING. Preparation of Transport System and Collection of Vaginal Sample Sample Collection is a critical step. Personnel collecting vaginal fluid specimens for transport with this system should be well trained on adequate sample collection technique. All samples for use with the Affirm VPIII Microbial Identification Test must be collected using the materials provided with this system. 1. Open the seal on outer plastic pouch of Affirm VPIII Ambient Temperature Transport System and remove all components [each plastic pouch contains enough material for the collection and transport of one vaginal specimen]. 2. Tear open the foil pouch and remove the ATTS Reagent Dropper. 3. Break ampule in ATTS Reagent Dropper by firmly squeezing vial with finger and thumb. CAUTION: Break ampule close to its center one time only. Do not manipulate dropper any further, as the plastic may puncture and injury may occur. 4. Dispense reagent from ATTS Reagent Dropper into Sample Collection Tube. 5. Peel wrapper to expose patient swab. Remove swab. Discard wrapper. 6. Collect patient specimen/take sample. 3

Place the patient in position for a pelvic examination. Insert an UNLUBRICATED speculum (WITHOUT JELLY OR WATER) into the vagina to permit visualization of the posterior vaginal fornix. Using the sterile polyester-tip swab, obtain a sample from the posterior vaginal fornix. Twist or roll the swab against the vaginal wall two or three times, ensuring the entire circumference of the swab has touched the vaginal wall. Swab the lateral vaginal wall while removing the swab. 7. Immediately place the patient swab in the Sample Collection Tube containing the ATTS Reagent. 8. Break swab shaft at pre-scored line just above the top of the tube. Discard remaining shaft into an infectious waste container. 9. Place the Sample Collection Cap over the exposed end of the swab and firmly press the cap onto the Sample Collection Tube. The cap will snap onto the tube when it is properly seated. 10. Label the Sample Collection Tube with patient/lab identification information. Include date and time that sample was taken. Transport and Storage of Vaginal Sample: Send the capped Sample Collection Tube to the lab by sealing it in the emptied outer plastic pouch of the Affirm VPIII Ambient Temperature Transport System. Label plastic pouch with appropriate information. VIII. LIMITATIONS OF THE PROCEDURE The Affirm VPIII sample collection and specimen processing procedure has been designed for use with vaginal specimens that are only to be tested using the Affirm VPIII Microbial Identification Test. The use of this procedure with other specimen types has not been established. The use of this product in a manner not specified above has not been established. Separate swabs should be used for other tests, e.g. culture or microscopic slide samples. This kit is not intended for collecting culture specimens. Swabs other than the ones provided with this system must not be used with the Affirm VPIII Ambient Temperature Transport System. 4

This system has been qualified for transport use at ambient conditions (15 30ºC) and refrigerated conditions (2 8ºC) for up to 72 h. When specimen transport times exceed 72 h, a reduction in sensitivity may be observed. Patient specimens must be collected immediately after the ATTS Reagent has been dispensed into the Sample Collection Tube. DO NOT pre-dispense the ATTS Reagent into the Specimen Transport Tube. IX. EXPECTED VALUES AND PERFORMANCE CHARACTERISTICS The Affirm VPIII Ambient Temperature Transport System has been designed to stabilize the nucleic acid of Candida species, Gardnerella vaginalis, and Trichomonas vaginalis during specimen transport at ambient temperature (15 30ºC) for up to 72 h. This system has also been qualified for transport use at 2 8ºC. Data is on file at Becton Dickinson Diagnostic Systems. X. AVAILABILITY 446253 Affirm VPIII Ambient Temperature Transport System, 10 systems per carton. 446255 Affirm VPIII Ambient Temperature Transport System, 100 systems per carton. XI. REFERENCES 1. National Committee for Clinical Laboratory Standards. 1997. Approved Guideline M29-A. Protection of laboratory workers from instrument biohazards and infectious disease transmitted by blood, body fluids and tissue. NCCLS, Wayne, Pa. 2. Garner, J.S. 1996. Hospital Infection Control Practices Advisory Committee, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Guideline for isolation precautions in hospitals. Infect. Control Hospital Epidemiol. 17:53-80. 3. U.S. Department of Health and Human Services. 1999. Biosafety in microbiological and biomedical laboratories, HHS Publication (CDC) 4 th ed U.S. Government Printing Office, Washington, D.C. 4. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the Article 16(1) of Directive 89/391/EEC). Official Journal L262, 17/10/2000, p. 0021-0045. 5

5. Recommendations for preventing transmission of Human Immunodeficiency Virus and Hepatitis B Virus to patients during exposure-prone invasive procedures. MMWR 1991, Vol. 40. No. RR-8. Approved By: Date Effective: 07/15/2002 Supervisor: Date: Director: Date: Reviewed: PI Rev. 10/1999 NCCLS Rev. 02/2002 6